Non-standard Design of Unstable Insulin Analogues with Enhanced Activity
Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor.
A Proposed Interaction Model of Insulin Molecules with its Receptor
Diabetes-associated Mutations in a beta-Cell Transcription Factor Destabilize an Antiparallel "mini-zipper" in a Dimerization Interface
The Relationship Between Insulin Bioactivity and Structure in the NH2-terminal A-chain Helix
Mapping the Functional Surface of Insulin by Design: Structure and Function of Novel A-chain Analogue
Tris, sodium citrate, acetone, phenol, pH 7.0, VAPOR DIFFUSION, HANGING DROP
1J73 contains the same sequence and structure, but substitution of Dab-A8 residue by Lysine
COMPOUND The crystallographic asymmetric unit of insulin consists of two insulin monomers each consisting of two heterochains. The entry presents coordinates for monomer 1 (chain indicators A and B) and monomer 2 (chain indicators C and D). There are two zinc ions per insulin hexamer located on the three-fold axis. The conformations of two monomers are different as the result of a change in conformation of the first eight residues of the B-chain.
This peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo sapiens (humans).
The biological assembly is a hexamer generated from the dimer in the asymmetric unit by the operations: -y, x-y, z and -x+y, -x, z.
A8-Lysine human insulin, insulin receptor, HORMONE-GROWTH FACTOR COMPLEX